Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.67
-4.71 (-2.03%)
AAPL  280.07
-4.08 (-1.44%)
AMD  218.01
+0.41 (0.19%)
BAC  54.48
+0.39 (0.73%)
GOOG  316.98
-3.64 (-1.13%)
META  666.96
+27.36 (4.28%)
MSFT  478.77
+1.04 (0.22%)
NVDA  183.76
+4.17 (2.32%)
ORCL  212.31
+4.58 (2.20%)
TSLA  449.45
+2.71 (0.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.